Crossmark

Metastasis enables immunogenicity through migrasome-mediated antigen release

Published Online: 2026-09-22

Authors

Jiang, Dong https://orcid.org/0009-0009-4646-9211
He, Jinzhao

Xie, Renxiang https://orcid.org/0000-0003-4194-3016
Shi, Minghui

Liu, Siyuan

Jia, Haohao

Yang, Bingjie

Ruan, Xiaojie

Tao, Xiaoyu

Xiang, Yuhan

Chen, Yining

Jiao, Lin

Feng, Xiaoyu

Yu, Li https://orcid.org/0000-0002-3757-0758
License Information

Text and Data Mining valid from 2026-09-22

Version of Record valid from 2026-09-22
More Information

Article History

Received: 10 June 2025

Accepted: 5 August 2026

First Online: 22 September 2026

Ethics

Competing interests: L.Y. is the scientific founder of Migrasome Therapeutics. The other authors declare no competing interests.

Document is current